USPTO trademark

XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES

RegisteredUSPTOWord and designClass 16

"XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES" is a word and design mark owned by Astellas US LLC, filed at the USPTO on February 3, 2015. It is registered and covers class 16 (Paper Goods and Printed Matter).

View Astellas US LLC portfolioGet this data via the API
Official USPTO record
XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES trademark as filed
As filed with the USPTO
Status
Registered
Since June 6, 2026
Filed
February 3, 2015
Registered
April 19, 2016
Expires
Not recorded
Application no.
86522592
Registration no.
4942589
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
1 class
Ownership

Who owns XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Astellas US LLC

Northbrook, United States

333 trademarks in the portfolioView company

Representative

Christopher Bolinger

Astellas

Goods and services

What the mark covers

The products and services XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES is filed for, grouped by Nice class.

  • Printed material, namely, brochures, booklets, posters, and fact sheets pertaining to prostate cancer, medical conditions, medical procedures, medical treatments, medications and recovery

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Attorney/dom.rep.revoked and/or appointed
  3. Teas revoke/app/change addr of atty/dom rep received
  4. Notice of acceptance of sec. 8 & 9 - e-mailed
  5. Registered and renewed (first renewal - 10 yrs)
  6. Registered - sec. 8 (10-yr) accepted/sec. 9 granted
  7. Post registration action mailed no response required
  8. Case assigned to post registration paralegal
  9. Teas section 8 & 9 received
  10. Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed

10 earlier steps on the official record.

FAQ

About XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES

Who owns the trademark "XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES"?

The USPTO trademark "XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES" (application 86522592) is owned by Astellas US LLC.

What is the status of "XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES"?

Its status at the USPTO is: registered.

When was "XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES" registered?

It was registered on April 19, 2016.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2a8e-5d08-7649-ab19-53b780ca68f7
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2a8e-5d08-7649-ab19-53b780ca68f7",
  "object": "trademark",
  "mark_text": "XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "86522592",
  "filing_date": "2015-02-03",
  "nice_classes": [
    16
  ],
  "owners": [
    {
      "name": "Astellas US LLC",
      "entity_id": "ent_019eb74a-ca18-730f-876b-7670c3b24c7e"
    }
  ]
}